David H. Schwartz, PhD | Head, Liability Support

Dr. Schwartz has led the Liability Support practice at ISS for the past 10 years. He excels at analyzing how science and law interact as well as communicating clear scientific information to business professionals and lawyers. His work as a "scientific detective" helps clients defend and support pharmaceuticals, medical devices, foods, and dietary supplements in the courts, the regulatory arena, and the market place.

Dr. Schwartz has extensive experience designing programs that critically review the scientific foundation for product development and major mass tort litigation. For 20 years, he has worked with the legal community evaluating product safety and defending products such as welding rods, cellular telephones, breast implants, wound care products, dietary supplements, general healthcare products, and a host of pharmaceutical agents (including: antidepressants, dermatologics, anti-malarials, anxiolytics, antipsychotics, and diet drugs).

In the course of his work, Dr. Schwartz has played a leading role in winning multi-billion dollar legal cases for clients. He counts the Daubert hearings as his biggest successes.  With the sheer weight of scientific data he’s able to collect, evaluate, and present as evidence, he’s helped counsel win cases before going to trial, thereby saving time and money.

Prior to founding ISS, Dr. Schwartz served as the Director of Scientific Litigation Support for the law firm, McCarter and English, where he was asked to evaluate the safety of Prozac. Since then, he has guided clients using scientific principles to defend products before, during, and after launch.

Dr. Schwartz received a Ph.D. in Neuroscience from Princeton University and postdoctoral training in Neuropharmacology and Neurophysiology from the Center for Molecular and Behavioral Neuroscience at Rutgers University.